BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 8448586)

  • 1. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS; Jones RL
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
    Lawrence RA; Jones RL; Wilson NH
    Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
    Lawrence RA; Jones RL
    Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
    Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
    Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
    Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E receptors in myometrial cells.
    Asbóth G; Phaneuf S; López Bernal AL
    Acta Physiol Hung; 1997-1998; 85(1):39-50. PubMed ID: 9530435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
    Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
    Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
    Shahbazian A; Heinemann A; Peskar BA; Holzer P
    Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
    Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
    Platelets; 2010; 21(5):329-42. PubMed ID: 20433310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
    Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
    Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
    Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
    Crankshaw DJ; Gaspar V
    J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of prostanoid receptors on rat neutrophils.
    Wise H; Jones RL
    Br J Pharmacol; 1994 Oct; 113(2):581-7. PubMed ID: 7834211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
    Talpain E; Armstrong RA; Coleman RA; Vardey CJ
    Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.